The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review
Authors
Keywords
-
Journal
MOLECULAR MEDICINE
Volume 24, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-23
DOI
10.1186/s10020-018-0060-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nonenzymatic glycosylation of human serum albumin and its effect on antibodies profile in patients with diabetes mellitus
- (2017) Alok Raghav et al. PLoS One
- Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up
- (2016) DIABETES CARE
- Skin fluorescence as a clinical tool for non-invasive assessment of advanced glycation and long-term complications of diabetes
- (2016) Bernardina T. Fokkens et al. GLYCOCONJUGATE JOURNAL
- Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory
- (2016) Sho-ichi Yamagishi et al. Journal of Diabetes
- The AGE-RAGE Axis and Its Relationship to Markers of Cardiovascular Disease in Newly Diagnosed Diabetic Patients
- (2016) Ma. Etzabel Villegas-Rodríguez et al. PLoS One
- Advanced glycation end-products as long-term predictors of death and reinfarction after an acute coronary syndrome
- (2015) Sergio Raposeiras-Roubín et al. Biomarkers in Medicine
- Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications
- (2015) Sho-ichi Yamagishi et al. Cardiovascular Diabetology
- Effects of Sevelamer Carbonate on Advanced Glycation End Products and Antioxidant/Pro-Oxidant Status in Patients with Diabetic Kidney Disease
- (2015) E. M. Yubero-Serrano et al. Clinical Journal of the American Society of Nephrology
- Elevated glycated albumin and reduced endogenous secretory receptor for advanced glycation endproducts levels in serum predict major adverse cardio-cerebral events in patients with type 2 diabetes and stable coronary artery disease
- (2015) Zhen Kun Yang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors
- (2015) Robyn L. McClelland et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Skin Autofluorescence Is Associated With 5-Year Mortality and Cardiovascular Events in Patients With Peripheral Artery Disease
- (2014) Lisanne C. de Vos et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Skin Advanced Glycation End Products Glucosepane and Methylglyoxal Hydroimidazolone Are Independently Associated With Long-term Microvascular Complication Progression of Type 1 Diabetes
- (2014) Saul Genuth et al. DIABETES
- Linagliptin Blocks Renal Damage in Type 1 Diabetic Rats by Suppressing Advanced Glycation End Products-Receptor Axis
- (2014) S. Nakashima et al. HORMONE AND METABOLIC RESEARCH
- Advanced glycation end products are associated with arterial stiffness in type 1 diabetes
- (2014) Gemma Llauradó et al. JOURNAL OF ENDOCRINOLOGY
- Advanced Glycation End Products and Diabetic Complications
- (2014) Varun Parkash Singh et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Increased serum concentrations of pentosidine are related to presence and severity of coronary artery disease
- (2014) Mohsen Kerkeni et al. THROMBOSIS RESEARCH
- Role of advanced glycation end products in cellular signaling
- (2014) Christiane Ott et al. Redox Biology
- Advanced glycation end-products induce endoplasmic reticulum stress in human aortic endothelial cells
- (2013) Christos Adamopoulos et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review
- (2013) Stefan Arsov et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Advanced Glycation End Products (AGE) and Diabetes: Cause, Effect, or Both?
- (2013) Helen Vlassara et al. Current Diabetes Reports
- No Racial Differences in the Association of Glycated Hemoglobin With Kidney Disease and Cardiovascular Outcomes
- (2013) E. Selvin et al. DIABETES CARE
- Neuropathy and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
- (2013) Catherine L. Martin et al. DIABETES CARE
- Advanced Glycation End Products Assessed by Skin Autofluorescence: A New Marker of Diabetic Foot Ulceration
- (2013) Julien Vouillarmet et al. Diabetes Technology & Therapeutics
- Advanced glycation end products and their relevance in female reproduction
- (2013) Z. Merhi HUMAN REPRODUCTION
- Inhibitory effect of soluble RAGE in disturbed flow-induced atherogenesis
- (2013) CHANG HOON HA et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Radical Roles for RAGE in the Pathogenesis of Oxidative Stress in Cardiovascular Diseases and Beyond
- (2013) Gurdip Daffu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update
- (2012) Francesco Piarulli et al. ACTA DIABETOLOGICA
- Serum Advanced Glycation End-Products and Receptors as Prognostic Biomarkers in Diabetics Undergoing Coronary Artery Stent Implantation
- (2012) Ying Shen et al. CANADIAN JOURNAL OF CARDIOLOGY
- Advanced Glycation End Products and Diabetic Cardiovascular Disease
- (2012) Anand Prasad et al. Cardiology in Review
- Effects of Sevelamer on HbA1c, Inflammation, and Advanced Glycation End Products in Diabetic Kidney Disease
- (2012) H. Vlassara et al. Clinical Journal of the American Society of Nephrology
- Pleiotropic Effects of Glucagon-like Peptide-1 (GLP-1)-Based Therapies on Vascular Complications in Diabetes
- (2012) Sho-ichi Yamagishi et al. CURRENT PHARMACEUTICAL DESIGN
- RAGE Deficiency Improves Postinjury Sciatic Nerve Regeneration in Type 1 Diabetic Mice
- (2012) J. K. Juranek et al. DIABETES
- The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-month, double-blind, randomized, placebo-controlled trial
- (2012) D. A. Fraser et al. DIABETES CARE
- Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study
- (2012) M. J. Noordzij et al. DIABETIC MEDICINE
- The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes
- (2012) Vincent M. Monnier et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Effect of Benfotiamine on Advanced Glycation Endproducts and Markers of Endothelial Dysfunction and Inflammation in Diabetic Nephropathy
- (2012) Alaa Alkhalaf et al. PLoS One
- Association of increased S100B, S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat models with ischemia–reperfusion injury
- (2011) Xue Ying Cai et al. ATHEROSCLEROSIS
- Soluble Receptor of Advanced Glycated Endproducts Is Associated With Plaque Vulnerability in Patients With Acute Myocardial Infarction
- (2011) Hun-Jun Park et al. CIRCULATION JOURNAL
- Higher Plasma Levels of Advanced Glycation End Products Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-year follow-up study
- (2011) J. W. Nin et al. DIABETES CARE
- Advanced Glycation End Products, Measured as Skin Autofluorescence and Diabetes Complications: A Systematic Review
- (2011) Dieuwke C. Bos et al. Diabetes Technology & Therapeutics
- Increased Accumulation of Skin Advanced Glycation End Products Is Associated with Microvascular Complications in Type 1 Diabetes
- (2011) Aleksandra Araszkiewicz et al. Diabetes Technology & Therapeutics
- Evidence for a role of advanced glycation end products in atrial fibrillation
- (2011) Sergio Raposeiras-Roubín et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats
- (2011) Lin Lu et al. Journal of Zhejiang University-SCIENCE B
- AGE restriction in diabetes mellitus: a paradigm shift
- (2011) Helen Vlassara et al. Nature Reviews Endocrinology
- The pathogenic role of Maillard reaction in the aging eye
- (2010) Ram H. Nagaraj et al. AMINO ACIDS
- Rates and Determinants of Coronary and Abdominal Aortic Artery Calcium Progression in the Veterans Affairs Diabetes Trial (VADT)
- (2010) A. Saremi et al. DIABETES CARE
- A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy
- (2010) A. Alkhalaf et al. DIABETES CARE
- Effects of alagebrium, an advanced glycation end-product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial
- (2010) Suzan Willemsen et al. EUROPEAN JOURNAL OF HEART FAILURE
- RAGE Modulates Hypoxia/Reoxygenation Injury in Adult Murine Cardiomyocytes via JNK and GSK-3β Signaling Pathways
- (2010) Linshan Shang et al. PLoS One
- Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes
- (2009) Lin Lu et al. ATHEROSCLEROSIS
- Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes
- (2009) H.L. Tam et al. ATHEROSCLEROSIS
- Decreased serum esRAGE level is associated with angiographically determined coronary plaque progression in diabetic patients
- (2009) Wen Hui Peng et al. CLINICAL BIOCHEMISTRY
- Elevation of the glycoxidation product Nε-(carboxymethyl)lysine in patients presenting with acute myocardial infarction
- (2009) Stefan Kralev et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Plasma N-ϵ-(carboxymethyl)lysine levels are associated with the extent of vessel injury after coronary arterial stenting
- (2009) Giuseppina Basta et al. CORONARY ARTERY DISEASE
- RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts
- (2009) Ravichandran Ramasamy et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Plasma Carboxymethyl-Lysine, an Advanced Glycation End Product, and All-Cause and Cardiovascular Disease Mortality in Older Community-Dwelling Adults
- (2009) Richard D. Semba et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Calcium-regulated intramembrane proteolysis of the RAGE receptor
- (2008) Arnaud Galichet et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Increased glycated albumin and decreased esRAGE concentrations are associated with in-stent restenosis in Chinese diabetic patients
- (2008) Lin Lu et al. CLINICA CHIMICA ACTA
- Role of Advanced Glycation End Products in Diabetic Neuropathy
- (2008) Kazuhiro Sugimoto et al. CURRENT PHARMACEUTICAL DESIGN
- Advanced Glycation End Products (AGEs) and their Involvement in Liver Disease
- (2008) Hideyuki Hyogo et al. CURRENT PHARMACEUTICAL DESIGN
- Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
- (2008) A. Soro-Paavonen et al. DIABETES
- Severity of diabetic microvascular complications is associated with a low soluble RAGE level
- (2008) N. Grossin et al. DIABETES & METABOLISM
- Advanced glycation end products and diabetic foot disease
- (2008) Maya S.P. Huijberts et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
- (2008) Su-Yen Goh et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
- (2008) William Duckworth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products
- (2007) Douwe J. Mulder et al. ATHEROSCLEROSIS
- Identification, classification, and expression of RAGE gene splice variants
- (2007) Barry I. Hudson et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started